drugset / Trial / NCT00067938

Bipolar Study in Adults at Least 18 Years of Age

NCT00067938

Phase 4 Completed 1200 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Bipolar study of tolerability, clinical response and patient satisfaction

Timeline

Start
2003-08
Primary completion
2004-08
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule

Indications